JP Morgan bets big on the future of healthcare

[ad_1]
JP Morgan is a foundational financial institution with investments and interests in all sectors around the world. In healthcare, the company made headlines just a few years ago when it launched Haven, a joint venture that optimizes healthcare costs and patient care experiences through innovative partnerships with Amazon and Berkshire Hathaway. I was. His Dr. Atul Gawande, a renowned surgeon and author, was tasked with leading the initiative, drawing on his many years of experience in healthcare and public health. However, just a few years later, Gawande resigned and Haven eventually closed.
Most recently, in 2021, JP Morgan launched Morgan Health as a separate business unit. The organization’s goal is to “help her 285,000 employees and dependents covered by JP Morgan’s health insurance plan and the millions of people in the United States who have insurance provided by their employer.” to improve health care. [The unit’s] Our mission is to accelerate the adoption of new approaches to care delivery that improve not only health outcomes but also the quality, affordability and equity of care. “
Morgan Health aggressively invests in “promising healthcare companies” that are meaningfully creating positive disruption in multiple areas, from home healthcare and virtual care delivery to healthcare analytics. In the latest move, Morgan Health has hired Dr. Cheryl Pegas to support the organization. Dr. Pegus was previously Walmart’s Executive Vice President of Health and Wellness, where he served as President, growing Walmart’s Healthcare vision, strategy and products nationally. According to a press release, Dr. Peggs said, “The team has renewed its commitment to population-based health initiatives, including investing in and scaling promising new care delivery models designed to improve health outcomes, especially among diverse populations. Our mission is to let you know that we are focusing on [in addition to advancing Morgan Health’s] Work and strategic investments dedicated to addressing gaps in mental and behavioral health, diabetes, heart disease, and other chronic conditions among enrollees. “
In fact, Morgan Health is taking its healthcare vision to the next level.
Manhattan, New York, USA – 04/19/2022: The front entrance of the new JP Morgan Chase headquarters … [+]
Financial institutions are increasingly turning their attention to the healthcare sector. Healthcare organizations have had a tough few years facing razor-thin profit margins and a myriad of complex challenges, including staffing shortages, rising costs, demand volatility, and cumbersome capital expenditures.
The presence of private equity in healthcare has exploded over the last decade, now reaching nearly $120 billion in deal value. Financial institutions are eager to enter the healthcare space because of the huge opportunity to improve care delivery, create meaningful disruption, and promise a return on investment. In an ideal world, private equity-based healthcare would provide access to tools, funding, and opportunities to improve healthcare services while ultimately balancing patient value and care with companies prioritizing care. should be increased.
Nonetheless, initiatives like Morgan Health are very important in the current healthcare landscape, as they can help provide funding and resources to companies that are meaningfully trying to truly create value. important to Take Vera Whole Health, backed by Morgan Health, for example. The company seeks to revolutionize the traditional primary care and care coordination model. Done right, Morgan Health could apply the lessons learned from this investment to ultimately improve access to care for millions of other patients. Dan Mendelsohn, CEO of Morgan Health, explains: […] Vera actively helps patients achieve their ideal physical, mental and social health. We also actively partner with other high-value healthcare providers to significantly improve the overall patient experience. “
In fact, this is just one example of a worthwhile investment that will significantly improve next-generation healthcare. There are still many opportunities like this, but only time will tell how JP Morgan will use its talent, resources and capital to ultimately improve the delivery of care.
[ad_2]
Source link










